| |
|
 |
Quality Control testing in process at each stage |
|
|
 |
On receipt, raw materials are subjected to Quality
Control (QC) sampling and testing and stored until
required for manufacturing products. The warehouse
facility has been built to pharmaceutical standards
and may be converted into production facilities
if required. |
|
|
|
Following warehousing, raw materials are dispensed
into the production process. Each dispensing bay
is equipped with a computer terminal that is linked
into the Enterprise Resource Planning IT system
which enables the progress of each batch to be tracked
through to end packaging and shipping. |
|
|
 |
Mixing and granulation is performed in dedicated
rooms with specialist machinery. This part of the
process is scalable to manage production over and
above current levels. |
|
|
 |
Mixed and granulated ingredients are then compressed
into tablet form or into hard-shell capsules as
required. Lipa Pharmaceuticals has the capacity
to substantially increase tablet compression output
within the current facility by increasing batch
sizes and by replacing the low speed tabletting
capacity with high-speed machines. |
|
|
 |
Tablets requiring coating are processed using
either water or ethanol/alcohol based coating processes.
Lipa Pharmaceuticals can produce film or enteric
coated products. |
|
|
 |
Lipa Pharmaceuticals then supplies final product
to its customers in two main packaged forms:
• In bulk, which accounts for approximately
50% of output; and
• Packed, ready for
end consumer use.
|
|
|
 |
|
|
|
 |
Once finished goods are ready for release they
are despatched to the customer’s warehouse.
|
| |
|
